4Singhai S,Mehta J,Desikan R,et al.Antitumor activity of thalidomide in refractory multiple myeloma.N Engl J Med,1999,341(21):1565~1571. 被引量:1
5Zan gafi M,Anaissie E,Barlogie B,et al.Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.Blood,2001,98(5):1614~1615. 被引量:1
6Tosi P,Zamagni E,Cellini C,et al.Neurological toxicity of long-term(》1yr) thalidomide therapy in patients with multiple myeloma.Eur J Haematol,2005,7(3):212~216. 被引量:1
1BJORKSRRAND BB, JUNGMAN P, SVENSSON H, et al. Allogeneic bone marrow versus autologous stem cell transplantation in muhiple myeloma-A retrospective case matched study from the European group for Blood and Marrow Transplantation[J]. Blood,1996, 87: 4711. 被引量:1